Representatives from the Center for Medicinal Cannabis Research met with Mario Zamora Gastélum, Federal Congressman of Mexico, and colleagues from Sinaloa to discuss opportunities for binational scientific collaboration in public health and drug policy.
The working session included CMCR leaders Igor Grant, JH Atkinson, Thomas Marcotte, and David Grelotti, along with Joseph Friedman, Eric Leas, and Ray Suhandynata, whose work spans opioid policy, public health, traceability, and quality control.
The discussion focused on potential frameworks for a strictly regulated therapeutic opioid model involving medical morphine from legal poppy conversion, as well as clinical applications of cannabis and CBD.
